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Abstract
Diabetic retinopathy and age-related macular degeneration are the leading causes of blindness in Western populations.
Although it is a matter of controversy, large-scale population-based studies have reported increased prevalence of age-
related macular degeneration in patients with diabetes or diabetic retinopathy. We hypothesized that metabolic syndrome,
one of the major risk factors for type 2 diabetes, would represent a favorable environment for the development of choroidal
neovascularization, the main complication of age-related macular degeneration. The fructose-fed rat was used as a model
for metabolic syndrome in which choroidal neovascularization was induced by laser photocoagulation. Male Brown Norway
rats were fed for 1, 3, and 6 months with a standard equilibrated chow diet or a 60%-rich fructose diet (n= 24 per time
point). The animals expectedly developed significant body adiposity (+17%), liver steatosis at 3 and 6 months,
hyperleptinemia at 1 and 3 months (two-fold increase) and hyperinsulinemia at 3 and 6 months (up to two-fold increase),
but remained normoglycemic and normolipemic. The fructose-fed animals exhibited partial loss of rod sensitivity to light
stimulus and reduced amplitude of oscillatory potentials at 6 months. Fructose-fed rats developed significantly more
choroidal neovascularization at 14 and 21 days post-laser photocoagulation after 1 and 3 months of diet compared to
animals fed the control diet. These results were consistent with infiltration/activation of phagocytic cells and up-regulation
of pro-angiogenic gene expression such as Vegf and Leptin in the retina. Our data therefore suggested that metabolic
syndrome would exacerbate the development of choroidal neovascularization in our experimental model.
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Introduction
Diabetic retinopathy (DR) and age-related macular degenera-
tion (AMD) are the leading causes of visual loss in Western
populations before and after the age of 50 years, respectively [1].
The association between DR and AMD remains controversial.
Large-scale population-based studies have reported increased
incidence or prevalence of AMD in patients with diabetes or
DR [2,3,4,5]. On the contrary, others have failed to find a similar
relationship such as the Framingham Eye Study [6] and smaller
case–control studies [7,8]. Metabolic syndrome (MetS) is defined
as a constellation of clinical criteria including visceral adiposity,
elevated blood pressure, hypertriglyceridemia, insulin resistance,
and elevated fasting glycemia. Its prevalence is high worldwide,
although it varies from one country to another and depends on
defining criteria. Using the NCEP (National Cholesterol Educa-
tion Program) definition, MetS reached 14.1% of the population
in France in 2006–2007 [9] and 22.9% in the US in 2010 [7].
MetS remains a major risk factor for the development of type 2
diabetes (T2D) [10]. The prevalence of diabetic retinopathy (DR)
in the diabetic population is high: from 9.9% in T2D adults 18
years and older to 28.5% after the age of 40 years [1]. Diabetes
plays a deleterious role on several structures in the eye including
the cornea, the lens, the optical nerve head and the retina [11,12].
Although no animal model of T2D recapitulates the late
proliferative stages of DR [13], most studies on the consequences
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of diabetes on the retina were restricted to the vascular effects of
hyperglycemia, including vasopermeability, endothelial cell pro-
liferation and promoted neovascularization [14,15]. However, far
less is known on the adaptation and characterization of the retinal
changes related to MetS. High-fructose diets have been associated
with metabolic changes and excess weight gain that are typical of
MetS and may predispose to T2D [14,16,17,18]. This concern
was supported mainly by observations in high-fructose-fed rodents
that reported hyperinsulinemia, increase of body fat, and
hepatomegaly associated with accumulation of lipids in the liver
[19,20]. The feeding of rats with high fructose is therefore a
suitable and pertinent model for MetS [14]. Choroidal neovascu-
larization (CNV) is the major complication of exudative AMD.
The rupture of Bruch’s membrane by laser impacts is a commonly
used technique to induce CNV in animals [21]. In our study, we
sought first to characterize the functional and gene expression
changes in the retina of fructose-fed rats, and second to evaluate
whether fructose-fed rats would be more prone to developing
CNV than control animals.
Materials and Methods
1. Ethical concerns
All procedures were conducted in accordance with the
Association for Research in Vision and Ophthalmology State-
ments for the use of animals in ophthalmic and vision research and
were approved by the local Animal Care and Use Committee
(Comite´ d’Ethique de l’Expe´rimentation Animale nr 105, Dijon,
France). Personal (nr 21CAE095) and institutional (nr
B21231010EA) agreements were obtained according to French
regulations.
2. Experimental diets
Standard and 60%-rich fructose diets (Table 1) were purchased
from Sniff Spezialdia¨ten Gmbh (Soest, Germany).
3. Animals
Male Brown Norway rats (6 weeks of age, Charles River,
L’Arbresle, France) were housed in controlled temperature
(2261uC) and humidity (55–60%) conditions with a 12-h light/
12-h dark cycle (Animalerie Expe´rimentale, CSGA, Dijon,
France). After a 7-day-long quarantine, the animals were
randomly allocated to the experimental groups corresponding to
the feeding of either of the two experimental diets during 1, 3 and
6 months (n=24 per diet and per time point) (Figure 1). Rats had
unrestricted access to food and deionized tap water.
4. Argon laser-induced choroidal neovascularization
(CNV) in rats
One week before the end of each dietary period (1, 3 or 6
months) (Figure 1), the rats were anesthetized by intraperitoneal
injection of ketamine (100 mg/kg, Imalge`ne 1000, Merial, Lyon,
France) and xylazine (10 mg/kg, Rompun 2%, Bayer, Puteau,
France). Pupils were dilated with 1% tropicamide (Mydriaticum,
Laboratoires The´a, Clermont-Ferrand, France). Laser photocoag-
ulation (532 nm, 300 mW, 50 ms, 75 mm, Vitra, Quantel
Medical, Clermont-Ferrand, France) was unilaterally performed
(5 to 7 spots per eye) in 8 animals per group. The laser spots were
delivered around the optic nerve using a slit lamp delivery system
and a glass coverslip as a contact lens. The validation of the injury
was ascertained at the time of the laser shot by the appearance of a
bubble.
5. Retinal and choroidal angiography
Retinal and choroidal angiography was performed every 7 days
for the 3 weeks following CNV induction by confocal scanning
laser ophthalmoscopy using Heidelberg Retinal Angiograph
(HRA1, Heidelberg Engineering, Germany) (n=8 rats per group)
(Figure 1). Rats were anesthetized by intraperitoneal injection of
ketamine (100 mg/kg, Imalge`ne 1000, Merial) and xylazine
(10 mg/kg, Rompun 2%, Bayer). Pupils were dilated with 1%
tropicamide (Mydriaticum, Laboratoires The´a). Fluorescein
(0.15 mL of 1% saline solution per 300 g body weight, Sigma
Aldrich, Saint Quentin Fallavier, France) and Indocyanine Green
(ICG) (0.15 mL of 0.4% saline solution per 300 g body weight,
Infracyanine, Serb, Paris, France) were injected intravenously via
the penile vein. Single pictures and depth scan movies were taken
between 5 and 10 min after dye administration. Photographs of
the retinal and the choroidal vasculature were recorded at 488 nm
for retinal vessel fluorescein angiography and at 795 nm for
choroidal ICG angiography. Barrier filters at 500 and 810 nm
Table 1. Composition of the experimental diets.
Standard diet Fructose-enriched diet
In g per kg of diet
Casein 180 180
Cornstarch 460 90
Sucrose 230 0
Fructose 0 600
Cellulose 20 20
Mineral mix (a) 50 50
Vitamin mix (b) 10 10
Fat: oil mix(c) 50 50
(a) Composition (g/kg): sucrose, 110.7; CaCO3, 240; K2HPO4, 215; CaHPO4, 215; MgSO4.7H2O, 100; NaCl, 60; MgO, 40; FeSO4.7H2O, 8; ZnSO4, 7H2O. 7; MnSO4.H2O, 2;
CuSO4.5H2O, 1; Na2SiO7.3H2O, 0.5; AlK(SO4)2.12H2O, 0.2; K2CrO4, 0.15; NaF, 0.1; NiSO4.6H2O, 0.1; H2BO3, 0.1; CoSO4.7H2O, 0.05; KIO3, 0.04; (NH4)6Mo7O24.4H2O, 0.02; LiCl,
0.015; Na2SeO3, 0.015; NH4VO3, 0.01.
(b) Composition (g/kg): sucrose, 549.45; retinyl acetate, 1; cholecalciferol, 0.25; DL-tocopheryl acetate, 20; phylloquinone, 0.1; thiamine HCl, 1; riboflavin, 1; nicotinic acid,
5; calcium pantothenate, 2.5; pyridoxine HCl, 1; biotin, 1; folic acid, 0.2; cyanocobalamin, 2.5; choline HCl, 200; DL-methionine, 200; p-aminobenzoic acid, 5; inositol, 10.
(c) Composition of the oil mix (%): Rapeseed oil, 18. 7; Oleic oil, 38.1; Sunflower oil, 5; Palm oil, 38.1. Omega 6 to omega 3 ratio = 7.5.
doi:10.1371/journal.pone.0112450.t001
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provided the optimal cutoff at the respective peak fluorescence
emission values for the two types of angiography. The size of the
square scan field was set at 20u and 10u.
6. Semi-quantitative analysis of laser-induced CNV
CNV was semi-quantified in a double-blind manner by two
independent investigators on images from ICG angiography 2 and
3 weeks after laser-induced CNV using ImageJ software. The
CNV area was delimited on grey-scale images centered on the
optic nerve head and measured in pixels. In the 256 values of the
grey scale, the lower limit for the detection of CNV (i.e.,
hyperfluorescence) was 119613 compared to 80617 for back-
ground noise (mean 6 SD, n=8 independent determinations in
different fundi). The ratio of the fluorescence of each laser impact
to the optic nerve head area was calculated and averaged per eye
(n=5 impacts per eye, n=8 rats per group).
7. Electroretinography
The electroretinograms (ERG) were recorded after 1, 3, and 6
months of feeding (n=16 rats per group) (Figure 1), according to
previously described procedures and ISCEV (International Society
for Clinical Electrophysiology of Vision) guidelines [22]. Rats were
dark-adapted overnight before the experiments. All further
procedures were carried out under dim red light (l,650 nm) at
a constant temperature of 25uC. Rats were anesthetized by
intramuscular injection of ketamine (100 mg/kg, Imalge`ne 1000,
Merial) and xylazine (10 mg/kg, Rompun 2%, Bayer). Pupils were
dilated with 1% tropicamide (Mydriaticum, Laboratoires Thea).
After 10 min, rats were positioned on a warming plate, and the
corneal electrodes were put in place. The ERG was recorded via
corneal electrodes (thin gold wire with a 3-mm ring end) and
reference and ground electrodes (silver needle) placed on the
forehead and tail, respectively. The recording setup featured a
Ganzfeld bowl, an amplifier, and a computer-based control and
recording unit (RETI port/scan 21, Stasche & Finger GmbH,
Roland Consult, Brandenburg, Germany). ERG responses were
recorded from both eyes simultaneously after the rats were placed
in the Ganzfeld bowl.
The first ERG examination corresponded to the scotopic single
flash, scotopic threshold response (STR) and oscillatory potential
(OP) recordings (n=8 rats per group). The band-pass filter width
was 1–300 Hz for the recording procedure of scotopic single-flash
responses. The stimuli of the scotopic single-flash were recorded
with ten increasing intensities from 0.0003 cd.s/m2 to 10 cds/m2.
These responses were averaged with an inter-stimulus interval of
5 s (from 1 to 10 cd.s/m2) or 17 s (up to 0.3 cd.s/m2). The band-
pass filter width was 0.2–30 Hz for the STR recording procedure.
The STR stimuli were recorded with three increasing intensities:
24.60 log,24.32 log, and24.02 log cd.s/m2. A 2 s inter-stimulus
interval was used between these stimuli. After amplification, the
signal was digitized and processed. The amplitude and latency of
the a- and b-waves were analyzed as previously described [23].
OPs were recorded as previously published [24]. The band-pass
filter width was 200–500 Hz. Two stimuli were applied with an
inter-stimuli interval of 17 s. After amplification, the signal was
digitized and processed on the basis of means of amplitude and
Figure 1. Flow chart of the experimental procedure. CNV: choroidal neovascularization, ERG: electroretinography.
doi:10.1371/journal.pone.0112450.g001
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time-latency measurements of each of the four typically charac-
terized peaks (OP1–OP4) [25]. The second flicker ERG exami-
nation consisted in fixed frequency 8.02 Hz light stimulation, in
order to avoid subharmonic of the frequency of the power supply
(set at 50 Hz) (n=8 rats per group). The responses were recorded
at ten increasing intensities from 0.0003 cd.s/m2 to 10 cd.s/m2
with an inter-stimulus interval of 0.1247 s.
8. Body composition analysis
As mentioned in Figure 1, whole body composition was
analyzed by quantitative magnetic resonance imaging (EchoMRI
500, EchoMRI, Houston, Texas; Plateforme de phe´notypage du
petit animal, Universite´ de Bourgogne, AgroSup Dijon, France).
Animals were adapted to the environment of the EchoMRI
analyzer at least 12 h before measurement with free access to food
and water. Scans were taken by placing animals in a thin-walled
plastic cylinder (3 mm thick, 6.8- or 8.2-cm inner diameter, based
on body weight), with a cylindrical plastic insert added to limit the
movement of the animals. Within the tube, the animals were
briefly subjected to a low-intensity (0.05 Tesla) electromagnetic
field to measure fat, lean mass, free water, and total body water, as
described by Tinsley [26]. Briefly, this system generates a signal
that modifies the spin patterns of hydrogen atoms within the
subject, and uses an algorithm to evaluate the resulting T1 and T2
relaxation curves specific to each of the four components
measured: fat mass, lean muscle mass equivalent, total body
water, and free water. Quantitative magnetic resonance scans
were taken in triplicate (n=8 rats per group).
9. Collection of samples
The animals (n=16 rats per group) were fasted overnight. The
rats were deeply anesthetized with pentobarbital (Ceva, Sante´
animale, Libourne, France). Blood was collected from the
abdominal artery in EDTA tubes and plasma was prepared by
centrifugation (20 min, 3000 rpm) and stored at 280uC until
further analysis. Rats were then euthanized by exsanguination.
Retinas were dissected and stored in RNAlater solution (Qiagen,
Courtaboeuf, France) until RNA extraction. The liver was
collected and stored at 280uC until lipid and fatty acid analyses.
Eyes were collected at the end of the CNV protocol for
flatmounting of the retinas (see paragraph 2.13), two weeks after
the end of the diet period (n=8 per group) (Figure 1).
10. Lipid analyses
Lipids were extracted from the liver (n=8 per group) according
to the Folch method [27] and submitted to transmethylation of the
fatty acids using boron trifluoride in methanol according to
Morrison and Smith [28]. Fatty acid methyl esters were
subsequently extracted with hexane and analyzed using gas
chromatography on a Hewlett Packard Model 5890 gas
chromatograph (Palo Alto, CA, USA) using a CPSIL-88 column
(100 m, 0.25 mm i.d., 0.20-mm film thickness, Varian, Les Ulis,
France) equipped with a flame ionization detector. Hydrogen was
used as the carrier gas (inlet pressure, 210 kPa). The oven
temperature was held at 60uC for 5 min, increased to 165uC at
15uC/min and held for 1 min and then to 225uC at 2uC/min and
finally held at 225uC for 17 min. The injector and the detector
were maintained at 250uC. Fatty acid methyl esters were identified
by comparison with commercial and synthetic standards (Sigma
Aldrich, L’Isle d’Abeau, France). The data were processed using
the EZChrom Elite software (Agilent Technologies, Massy,
France) and reported as a percentage of the total fatty acids.
The distribution of lipids into phospholipids, triacylglycerols,
free fatty acids, free cholesterol, and cholesteryl esters in the neural
retina (n=8 per group) was determined using a combination of
thin-layer chromatography on silica gel-coated quartz rods and
flame ionization detection (Iatroscan system, Iatron, Tokyo,
Japan), according to Ackman’s technique [29] and published by
our group [30]. The values obtained for each compound were
corrected according to their response factor using specific
calibration curves, as previously published [31]. Data were
reported as a percentage of the total lipids in the sample.
11. Plasma analyses
Glycemia was evaluated using a blood glucose system (One
Touch Ultra, Lifescan) (n=8 rats per group). Cholesterol,
triacylglycerol, HDL, LDL, and fructosamine were quantified by
standard automatic analyzers at the Clinical Chemistry Depart-
ment of the Dijon University Hospital (Dijon, France) (n=8 rats
per group). Plasma insulin and leptin levels (n=8 rats per group)
were quantified on a 96-well plate using the Rat Metabolic
Magnetic Bead Panel and assessed by Luminex technology (Biorad
Bioplex 200 system, Life Sciences, Marnes-la-Coquette, France).
The analyses were performed according to the manufacturers’
protocols (Milliplex kit, Merck Millipore).
12. Analysis of gene expression in the neurosensory
retina
Total RNA from the neurosensory retina (n=8 in each group)
were extracted using a commercial kit following the manufactur-
er’s procedure (RNAqueous, Applied Biosystems, Courtaboeuf,
France). cDNA were prepared using oligo-dT as the primer and
the High-Capacity RNA-to-cDNA Master Mix from Applied
Biosystems. The quality and concentration of the cDNA samples
were checked by qPCR analysis of glucuronidase beta (GUSB)
expression using TaqMan technology (ABI7900 Fast Real-Time
PCR system, Applied Biosystems). The expression of 61 genes
(Table 2), including four control genes and genes coding for lipid
metabolism, fatty acid transport, inflammation, neovasculariza-
tion, and chemokines, was analyzed using qPCR with the
TaqMan Array Plates FAST Custom (ABI7900 Fast Real-Time
PCR system, Applied Biosystems).
13. Quantification of phagocytic cells in flat-mounted
retinas
Rats fed 3 months with standard or fructose diets and submitted
to laser-induced CNV were euthanized and enucleated 3 weeks
after laser photocoagulation (Figure 1). The eyeballs were fixed in
4% paraformaldehyde (Sigma-Aldrich, Saint Quentin Fallavier,
France) for 50 min, washed in PBS azide and stored at 4uC in PBS
until preparation of retinal flatmounts. The cornea was incised, the
lens was taken out, and four radial cuts were made on the eyecups.
The vitreous was removed with forceps, and the retinas were
gently isolated and flattened on microscope slides and circled by a
hydrophobic pen (Dakopen, Dakocytomation, Trappes, France) in
200 mL of a blocking solution (1% BSA in PBS pH 6.8, 0.5%
Tween 20) for 1 day and stored at 4uC under stirring. PBLec
washing solution (PBS1X, pH 6.8, 0.1 mM Cacl2, 0.1 mM
MgCl2, 1% Tween 20) was used twice to wash the retinal
flatmounts (200 mL per washing for 5 min). Primary mouse
antibody raised against rat anti-CD68 (dilution 1:100)
(MCA341R, AbD Serotec) was incubated overnight at 4uC under
stirring. Five washings with PBS1X were then carried out, and
retinal flatmounts were incubated with secondary antibody
(dilution 1:100) (A1101, anti-mouse Alexa 488, Life Technologies)
for 2 h. Five washings in PBS1X were performed and the slides
were coverslipped with a fluorescence mounting medium
Metabolic Syndrome and Retinal Neovascularization
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Table 2. List of the genes which expression was analyzed by RT-qPCR.
Gene symbol Gene name Reference sequence
Abca1 ATP-binding cassette, subfamily A (ABC1), member 1 NM_178095.2
Abca4 ATP-binding cassette, subfamily A (ABC1), member 4 NM_001107721.1
Abcg1 ATP-binding cassette, subfamily G (WHITE), member 1 NM_053502.1
Akt2 v-akt murine thymoma viral oncogene homolog 2 NM_017093.1
Alox12 arachidonate 12-lipoxygenase NM_001105798.1
Alox5 arachidonate 5-lipoxygenase NM_012822.1
Angptl3 angiopoietin-like 3 NM_001025065.1
Apoa4 apolipoprotein A-IV NM_012737.1
Apob apolipoprotein B NM_019287.2
Apoe apolipoprotein E NM_138828.3
Asmt acetylserotonin O-methyltransferase NM_144759.2
Ccl2 chemokine (C-C motif) ligand 2 NM_031530.1
Cd36 CD36 molecule (thrombospondin receptor) NM_031561.2
Cyp27a1 cytochrome P450, family 27, subfamily a, polypeptide 1 NM_178847.2
Cyp46a1 cytochrome P450, family 46, subfamily a, polypeptide 1 NM_001108723.1
Cyp7a1 cytochrome P450, family 7, subfamily a, polypeptide 1 NM_012942.1
Edn1 endothelin 1 NM_012548.2
Fas Fas (TNF receptor superfamily, member 6) NM_139194.2
Foxa2 forkhead box A2 NM_012743.1
Gfap glial fibrillary acidic protein NM_017009.1
Hif1a hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) NM_024359.1
Hmgcr 3-hydroxy-3-methylglutaryl-Coenzyme A reductase NM_013134.2
Htra1 HtrA serine peptidase 1 NM_031721.1
Igf1 insulin-like growth factor 1 NM_001082477.2
Il1b interleukin 1 beta NM_031512.2
Il6 interleukin 6 NM_012589.1
Insig1 insulin induced gene 1 NM_022392.1
Ipcef1 nteraction protein for cytohesin exchange factors 1 NM_001170799.1
Irs1 insulin receptor substrate 1 NM_012969.1
Itgb2 integrin, beta 2 NM_001037780.2
Lcat lecithin cholesterol acyltransferase NM_017024.2
Ldlr low density lipoprotein receptor NM_175762.2
Lep leptin NM_013076.3
Lepr leptin receptor NM_012596.1
Lpl lipoprotein lipase NM_012598.2
Lrp1 low density lipoprotein-related protein 1 (alpha-2-macroglobulin receptor) NM_001130490.1
Mapk8 mitogen-activated protein kinase 8 NM_053829.1
Mtnr1a melatonin receptor 1A NM_053676.2
Mtnr1b melatonin receptor 1B NM_001100641.1
Mttp microsomal triglyceride transfer protein NM_001107727.1
Nos2 nitric oxide synthase 2, inducible NM_012611.3
Nox1 NADPH oxidase 1 NM_053683.1
Nox3 NADPH oxidase 3 NM_001004216.1
Nr1d1 nuclear receptor subfamily 1, group D, member 1 NM_001113422.1
Nr1h3 nuclear receptor subfamily 1, group H, member 3 NM_031627.2
Pltp phospholipid transfer protein NM_001168543.1
Ppara peroxisome proliferator activated receptor alpha NM_013196.1
Ppard peroxisome proliferator-activated receptor delta NM_013141.2
Rela v-rel reticuloendotheliosis viral oncogene homolog A (avian) NM_199267.2
Rxra retinoid X receptor alpha NM_012805.2
Metabolic Syndrome and Retinal Neovascularization
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(Dakocytomation, Trappes, France). Retinas were examined
under a confocal fluorescence microscope (Leica SP2, Leica
Microsystems, Wetzlar, Germany, Plate-forme DIMACELL,
Dijon, France). Images (165 mm6165 mm) were taken for quan-
tification of the fluorescence in the experimental and fellow retinas
using ImageJ software. Images from confocal fluorescence
microscopy were converted in binary mode. The number of
pixels corresponding to the value of 255 on the gray scale was
considered as CD68-positive cells. Five images per eye for each
diet (standard and fructose diets in both experimental and fellow
retinas) were evaluated and averaged.
14. Statistical analyses
All analyses were conducted using GraphPad Prism software
version 4.0. The level of statistical significance of the two-tailed
tests was set at p#0.05 and 0.01. A nonparametric Mann &
Whitney test was used to compare body fat, circulating insulin and
leptin levels, fatty acids, and lipid classes in the liver and non
parametric Kruskal-Wallis test for quantification of CNV and
CD68-immunostaining in the standard and fructose groups.
Statistical analysis of gene expression was performed using
integrated statistical analysis of data assist software (Student t-test)
and a heat map was performed using the fold change values. Fold
changes above the value of 1.5 was considered as significant. Dark
green was used to represent a 10-fold change downregulation of
gene expression, dark red was used to represent 7-fold change
upregulation of gene expression. The levels of statistical signifi-
cance were set at p#0.1, 0.05, and 0.01.
Results
1. Fructose diet triggered metabolic syndrome in the rat
The fructose diet did not affect body weight (data not shown),
but significantly increased body fat by 17% compared to rats of the
control group at the corresponding ages (Figure 2). Plasma
analyses revealed significant hyperleptinemia after 1 and 3 months
of fructose feeding (p=0.03 and 0.001, respectively), and
hyperinsulinemia at 3 and 6 months (p=0.05 and 0.04,
respectively) (Figure 3). On the other hand, glycemia and plasma
levels of HDL and LDL cholesterol and fructosamine remained
constant (data not shown). The analysis of the lipid classes in the
liver revealed a significant increase of triacylglycerol levels after 3
and 6 months of diet (five- and threefold increase, respectively,
Figure 4), highlighting the development of liver steatosis induced
by the fructose diet. As expected, increased liver triacylglycerols
were associated with accumulation of palmitic and oleic acids
(Table 3), which remain the prominent fatty acids accumulating at
the time of steatosis [32,33].
2. Metabolic syndrome favored laser-induced choroidal
neovascularization in the rat via activation/infiltration of
phagocytic cells in the retina
CNV did not develop 1 week after laser, as illustrated by the
lack of fluorescence in the scars created by the laser spots
(Figure 5A). Hyperfluorescent areas appeared in the lesions
compared to the surrounding choroid after 2 (images not shown)
Table 2. Cont.
Gene symbol Gene name Reference sequence
Rxrb retinoid X receptor beta NM_206849.3
Rxrg retinoid X receptor gamma NM_031765.1
Slc2a2 solute carrier family 2 (facilitated glucose transporter), member 2 NM_012879.2
Slc2a4 solute carrier family 2 (facilitated glucose transporter), member 4 NM_012751.1
Srb1 scavenger receptor class B, member 1 NM_031541.1
Tnf tumor necrosis factor (TNF superfamily, member 2) NM_012675.3
Vegfa vascular endothelial growth factor A NM_001110333.1
Housekeeping genes
Gadd45a growth arrest and DNA-damage-inducible, alpha NM_024127.2
Gusb glucuronidase, beta NM_017015.2
B2m beta-2 microglobulin NM_012512.2
18S Ribosomal 18S sub-unit X_03205
doi:10.1371/journal.pone.0112450.t002
Figure 2. Body fat is increased in rats fed with a 60%-rich
fructose diet. Body fat (expressed as % of body mass) was quantified
by EchoMRI in the rat after 1, 3, and 6 months of feeding with either the
standard (S) or 60%-rich fructose (F) diet. * and ** statistically different
at p#0.05 and 0.01, respectively (Mann & Whitney test). The bottom
and top of the box are the first and third quartiles, and the band inside
the box is the median. The ends of the whiskers are 1 standard
deviation above and below the mean of the data (n= 8 rats per group).
doi:10.1371/journal.pone.0112450.g002
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and 3 weeks (Figure 5A). These areas correspond to filling of the
vessels with ICG dye and thus to the neovascularization process.
Figure 5B presents semi-quantitative CNV data. A significant
CNV enhancement was observed after 1 month of fructose-
feeding 2 and 3 weeks after laser injury compared to the standard
diet (p=0.03, p=0.0003, respectively). After 3 months of feeding,
fructose-fed rats showed exacerbated CNV development only at
week 2 after laser impacts (p=0.0065). No significant CNV was
observed after 6 months of feeding with the high-fructose diet (p.
0.05). Analysis of CD68-positive immunostaining in flat-mounted
retinas (Figure 6A) showed a significant increase of CD68
expression in fructose-fed rats compared to standard-fed animals
in fellow retinas (p#0.01, Figure 6B). CNV significantly enhanced
CD68 immunostaining in fructose-fed rats, suggesting massive
infiltration of circulating macrophages and/or activation of
resident microglia.
3. Fructose diet-modulated gene expression in the retina
Figure 7 presents the data of gene expression in the retina of
fructose-fed rats by comparison to animals fed the standard diet.
The results show significant upregulation of the proangiogenic
genes Vegfa at 1 month (p#0.01), 3 months (p#0.05), and 6
months (p#0.05) and Hif1a at 6 months (p#0.1). Meanwhile
Leptin (p#0.1) and Mapk8 genes (p#0.01) were upregulated at 1
month. In contrast, melatonin receptor genes (Mtnr1a and
Mtnr1b) were downregulated after 1 and 3 months of diet (p#
0.1). At 3 months, fructose feeding induced upregulation of several
genes coding nuclear factors (Rxrg, Nr1h3, p#0.1), proteins
involved in lipid metabolism including Pltp (p#0.1), Lcat, and
Cd36 (p#0.05), cell death inflammation (Tnf, p#0.1), and
diabetes (Irs1, Slc2a2, p#0.1). After 6 months of fructose feeding,
we noted down regulation of genes involved in photoreceptor
signaling (Abca4, p#0.1) and lipid metabolism: Apoa4 and ApoB
(p#0.05), although Pltp remained upregulated (p#0.1).
4. Rod sensitivity to light was partially lost in metabolic
syndrome
The amplitudes and implicit times of the a- and b-waves of the
ERG are shown in Figure 8A. No significant effect of fructose
feeding was reported, although a trend was observed for the
reduction of the b-wave amplitude in fructose-fed rats. To further
characterize the changes induced by the fructose diet, additional
protocols were performed. Flicker ERG is a suitable technique to
specifically record rod and cone sensitivity to light stimulus [34]. It
was recorded after 1, 3, and 6 months in both fructose-fed rats and
animals fed the standard diet. The results are shown in Figure 8B.
The data demonstrated no effect of fructose on rod or cone
sensitivity at 1 and 3 months. On the contrary, the data obtained
in rats fed with fructose for 6 months exhibited a shift to the right
Figure 3. Insulinemia and leptinemia are increased in rats fed with a 60%-rich fructose diet. Plasma insulin and leptin (expressed in pg
per mL of plasma) were quantified in the rat after 1, 3, and 6 months of feeding with either the standard (S) or 60%-rich fructose (F) diet. * and **
statistically different at p#0.05 and 0.01, respectively (Mann & Whitney test). Values are given as means 6 SD (n= 8 rats per group).
doi:10.1371/journal.pone.0112450.g003
Figure 4. Liver steatosis is increased in rats fed with a 60%-rich fructose diet. Liver steatosis was evaluated by quantifying triacylglycerols
(expressed in % of total lipids) in the liver of the rat after 1, 3, and 6 months of feeding with either the standard (S) or 60%-rich fructose (F) diet. **
statistically different at p#0.01 (Mann & Whitney test). Values are given as means 6 SD (n=8 rats per group).
doi:10.1371/journal.pone.0112450.g004
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of the maximal response of rods (D=0.5 log(I)). This illustrates
that a higher light intensity was required to reach the maximal
response of rods, suggesting partial loss of rod sensitivity induced
by the fructose diet. Oscillatory potentials (OPs) were further
analyzed. The amplitudes and implicit times of the four OPs are
presented in Figure 8C. A significant decrease of OP2 was
observed in fructose-fed rats as illustrated in the insert of
Figure 8C (p#0.05).
Discussion
MetS is a major risk factor for T2D and DR. Most studies on
DR focused on the mechanisms and consequences of hypergly-
cemia in retinal vessels. These data highlighted the prominent role
of oxidative stress, inflammation and hemostatic factors including
VEGF secretion in the complications of DR, namely retinal edema
and retinal neovascularization [12,35,36]. Our data showed that
feeding Brown Norway rats for 1 and 3 months with a 60%-rich
fructose diet induced body adiposity and hyperleptinemia.
Hyperinsulinemia was reported after 3 and 6 months of diet
(Figure 3), suggesting the development of insulin resistance in a
prediabetic state [37]. These data are consistent with previous
reports using fructose diet as a model to induce insulin resistance
in rats [38,39] and more generally describing some features of
MetS [40].
Most large-scale population-based studies reported increased
incidence or prevalence of AMD in patients with diabetes or DR
[2,3,4,5], with the exception of the Framingham Eye Study [6] or
smaller case–control studies [7,8]. The matter is subject to
controversy. At least two studies reported a consistent and similar
association between diabetes and neovascular AMD, with an odds
ratio of 1.88 (95% CI, 1.07–3.31) in the Age-Related Eye Disease
Study [2] and 1.81 (95% CI, 1.10–2.98) in the EUREYE study
[5]. Others found an association with geographic atrophy [4].
Nevertheless and interestingly, in those reports diabetes and early
AMD appeared to be unrelated. These data reinforced our
hypothesis that MetS as a risk factor for T2D is a promoting factor
for neovascular complications in the retina.
On the one hand, the primary objective of this study was to
characterize the adaptation of the retina to MetS. Flicker ERG
data revealed partial loss of rod sensitivity to light stimulus after 6
months of fructose feeding (Figure 8B). This is consistent with
downregulation of the Abca4 gene after 6 months of fructose
feeding, accounting for ABCA4 being physiologically involved in
the retinoid cycle and mutations in Abca4 being associated with
cone and rod dystrophies [41]. It was previously reported that the
sensitivity of photoreceptors was affected in DR and could be
attributed to transduction abnormalities [42]. Alterations of
photoreceptors were consistently observed in a model of strepto-
zotocin-induced diabetic rats [43]. We also suggested a slight
decrease of functionality of inner retinal cells by scotopic standard
ERG, since the b-wave amplitude was lowered, although the
difference from controls failed to reach statistical significance. We
observed a decrease of OP2 amplitude in fructose-fed rats.
Although the exact origin of OPs is still uncertain, OPs most
probably reflect neuronal activity of bipolar cells and amacrine
cells [44]. Several studies pointed out the association between
alterations of OPs and diabetes. Indeed OP2 and OP4 responses
were delayed in streptozotocin-induced diabetic rats [45]. Previous
studies reported the association between the reduction of OP
amplitudes and the severity of diabetic retinopathy [46,47,48], or
even with the greater probability of developing DR [49].
Furthermore, patients with retinopathy and cone-rod diseases
presented delayed OP2 despite normal b-wave peak times [50].
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On the other hand, the secondary aim of our study was to
investigate whether MetS represents a favorable environment for
the development of CNV. Laser photocoagulation was used to
trigger neovascularization, as used by others [21]. Laser spots
create damage in the Bruch membrane that favors endothelial
cells, pericytes, and inflammatory cells entering the RPE and sub-
retinal space and forming CNV [21]. The present data showed
that the consequences of a fructose diet were associated with
exacerbated development of CNV after 1 and 3 months of feeding.
We observed massive infiltration of CD68-positive phagocytic cells
in the retina of rats submitted to laser injury and fed with fructose
compared to rats fed with the standard diet. These cells may either
be infiltrating macrophages and/or activated microglia. Enhanced
CNV was correlated with overexpression of VegfA and Leptin
genes in the retina. Leptin was shown to promote angiogenesis
[51] and retinal neovascularization [52]. Various growth factors,
including VEGF, are involved in the development of neovascu-
larization [36]. Our data consistently illustrated the association
between VEGF induction and enhanced CNV at early phases of
MetS, i.e., at 1 and 3 months. In our model, MAPK8 was
upregulated at 1 month. MAPK8 is a member of MAPK family
that encompasses Jun kinases (JNK). JNKs are critical factors in
the development of CNV, especially via the activation of
macrophages [53]. Using the same model of CNV development
as ours in mice, Du and coworkers elegantly showed that JNK is
required for macrophage recruitment and demonstrated that
JNKs inhibition and JNK1 knock-down reduced VEGF expres-
sion and lowered CNV [54]. In our model, MAPK8 overexpres-
sion was transient and restricted to 1 month, but might be
sufficient to promote macrophage infiltration in the retina and
further induce VEGF expression over a longer period of time, up
to 6 months. The cholesterol-27-hydroxylase (CYP27A1) gene was
significantly downregulated at 1 month in fructose-fed rats. The
association between CYP27A1 and enhanced development of
CNV in fructose-fed rats is consistent with data in CYP27A1
knock-out animals, showing vascular changes in the retina,
including sprouting of vessels from the choroid into the
neurosensory retina [55].
It must be noted that these changes in gene expression were
observed in retinas of fructose-fed animals that were not submitted
to CNV induction. Our findings therefore strongly support the
notion that MetS constitutes a favorable environment for the
development of CNV. In this context, the aforementioned effects
cannot be associated with the well-recognized role of hyperglycemia
Figure 5. Laser-induced choroidal neovascularization (CNV) is enhanced in rats fed with a 60%-rich fructose diet. A. Representative
images of choroidal indocyanine green angiography taken after 1 and 3 weeks post laser-induced CNV in rats fed with either the standard or 60%-rich
fructose diet. Images were taken at 20u by confocal scanning laser ophthalmoscopy at 795 nm. The black holes in the eye fundi at 1 week post laser-
induced CNV correspond to the breaks created by the laser spots (532 nm, 300 mW, 50 ms, 75 mm) in the retinal pigment epithelium and Bruch’s
membrane. CNV correspond to the filling of the new vessels by indocyanine green. B. Semi-quantification of CNV (ratio between the area of
indocyanine green fluorescence and optic disc area) at 2 and 3 weeks after laser-induced CNV in the rat fed during 1, 3, and 6 months with either the
standard (S) or 60%-rich fructose (F) diet. * and ** statistically different at p#0.05 and 0.01, respectively (Kruskal-Wallis test). Values are given as
individual data and means 6 SD (n= 8 rats per group).
doi:10.1371/journal.pone.0112450.g005
Metabolic Syndrome and Retinal Neovascularization
PLOS ONE | www.plosone.org 9 November 2014 | Volume 9 | Issue 11 | e112450
Figure 6. The number of CD68-positive cells is increased in the retina of rats fed with a 60%-rich fructose diet and submitted to
laser-induced choroidal neovascularization (CNV). A. Representative confocal images of CD68-positive cells (revealed by an Alexa 488-labelled
secondary antibody) in flat-mounted retinas of rats fed during 3 months with either the standard or the 60%-rich fructose diet and submitted or not
to laser-induced CNV. Images corresponding to 165 mm6165 mm of the retinal area were taken 3 weeks post laser-induced CNV. B. Quantification of
CD68-positive cells in flat-mounted retinas of rats fed during 3 months with either the standard or fructose diet, and submitted or not to laser-
induced CNV. ** statistically different at p#0.01 (Kruskal-Wallis test). Values are expressed in pixels of fluorescence in the area corresponding to
165 mm6165 mm of the retina; values are given as means 6 SD.
doi:10.1371/journal.pone.0112450.g006
Figure 7. Gene expression changes in the neurosensory retina induced by a 60%-rich fructose diet in the rat. Data of gene expression
were obtained by RT-qPCR and represented as a heat map. Fold change is indicated in the color scale, green indicates downregulation (up to 10-fold
repression) and red indicates upregulation (up to 7-fold induction) in the retina of rats fed with the 60%-rich fructose diet by comparison to the rats
fed with the standard diet at the corresponding ages (n=8 per group). 1, * and **, statistically different at p#0.1, 0.05 and 0.01, respectively (Student
t-test, n= 8 per group).
doi:10.1371/journal.pone.0112450.g007
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in DR, since the fructose diet did not induce elevated glycemia. Our
work therefore adds a new paradigm for the development of CNV
in the context of MetS. We suggest that MetS per se may trigger
mechanisms that are required for the development of neovascular-
ization, including gene expression changes (Mapk, Vegf, and Leptin
induction) and macrophage infiltration. Both circulating and in situ
leptin and VEGF may be the key factors for the development of
CNV in MetS, given that elevated leptin levels were reported to
increase the risk for MetS in humans [56]. In the present study,
elevated plasma leptin levels were associated with enhanced CNV at
1 and 3 months, whereas similar to controls hyperleptinemia was
reported at 6 months while no CNV was promoted. Secondly, in a
large clinical study investigating 1802 patients, elevated circulating
VEGF levels were positively associated with MetS [57].
We must acknowledge several limitations in our study. First,
feeding rats with fructose remains a model of MetS. Visceral
adiposity, elevated blood pressure, hypertriglyceridemia, insulin
resistance, and elevated fasting glycemia are hallmarks of MetS in
humans. Accounting the lifespan of rats compared to humans, our
results in rats 7 weeks of aged fed from 1 to 6 months may be
relevant to MetS in young to middle-aged adults. We reported
increased body fat, hyperinsulinemia, hyperleptinemia, but no
hypertriglyceridemia, as was previously shown in rats fed with
fructose [58]. Therefore, dietary exposure to fructose would
merely be considered as a partial model of MetS, by predisposing
cells and organs to chronic conditions of MetS [14].
This work showed, in a timely manner, the limitation of the
time-course consequences of fructose feeding since no hyperlepti-
nemia was detected after 6 months. This remediation of the effects
may likely be due to the organism’s long-term adaptive response.
Nevertheless, one should note the consistency of these results given
that leptin was considered a pro-angiogenic factor and no
increased CNV was observed at this time point. Fructose diets
are reported to promote oxidative stress and inflammation [14].
Although we did not ascertain these consequences in the retina,
our data showing macrophage infiltration and/or microglia
activation in the retina of fructose-fed rats is consistent with this
hypothesis. As recently published, macrophages may be activated
by oxidative damage in the retina and may participate in AMD
pathogenesis [59]. Secondly, laser-induced neovascularization
must be considered a model for CNV, but not for AMD. Until
now, no animal model shows all the features of AMD, especially
because no rodent model has a macula and spontaneously
develops CNV. Despite its artificial nature, the laser model is
currently the standard animal model of CNV and is widely used in
both fundamental research and preclinical trials [21].
In conclusion, this study clearly showed that feeding rats with a
high-fructose diet has detrimental consequences on the sensitivity
of rod photoreceptors to light. In addition, high fructose generates
a favorable environment for the development of neovasculariza-
tion in the retina.
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